Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma

PURPOSE: Definitive radiation therapy is the mainstay of treatment for early stage laryngeal squamous cell carcinoma (LSCC). However, up to 30% of the patients do not respond to radiotherapy. Unfortunately, we are unable to predict which tumors are likely to respond to radiation, and which will be r...

Descripción completa

Detalles Bibliográficos
Autores principales: Maia, Danielle, de Carvalho, Ana Carolina, Horst, Maria Aderuza, Carvalho, André Lopes, Scapulatempo-Neto, Cristovam, Vettore, Andre Luiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533949/
https://www.ncbi.nlm.nih.gov/pubmed/26264462
http://dx.doi.org/10.1186/s12967-015-0621-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4533949/
https://www.ncbi.nlm.nih.gov/pubmed/26264462
http://dx.doi.org/10.1186/s12967-015-0621-y

Ejemplares similares